- Home
- Products
- Customized FluoroAb™
- CD19
- Blinatumomab-OGreen
Blinatumomab-OGreen (CAT#: ADC-FL-395)
This product is comprised of an anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody (Blinatumomab) labeled with Oregon green. Oregon green is a green-fluorescent dye and it's excitation/emission is 501/526 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD19
- Alternative Names
- CD19; CD19 molecule; CD19 antigen; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4; B4; CVID3; MGC12802;
- Overview
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
- Overview
- Anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody, Blinatumomab
- Generic name
- Blinatumomab
- Species Reactivity
- Human
- Name
- Oregon green
- Color
- Green
- Excitation⁄Emission (nm)
- 501/526
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD19 MAb (Clone 34)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16320)
- Anti-TNFRSF8 MAb (Clone 17)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12844)
- Anti-CTLA4 MAb (Clone 10)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1242)
- Anti-SLAMF7 MAb (Clone 3)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4567)
- Anti-SOST MAb (Clone 4)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15335)
- Anti-CD19 MAb (Clone 5)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3476)
- Anti-GPNMB MAb (Clone 3)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1024)
- Anti-FN1 MAb (Clone 4)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3915)
- Anti-MSLN MAb (Clone 9)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8696)
- Anti-ITGA4+ITGB7 MAb (Clone 2)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11575)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-395. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-779 | Anti-CD19 (Blinatumomab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-776 | Anti-CD19 (Blinatumomab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2516 | Anti-CD19 (Denintuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2520 | Anti-CD19 (Denintuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-775 | Anti-CD19 (Taplitumomab paptox)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
